Breethe Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $55M

Breethe General Information

Description

Developer of medical devices designed to offer wearable ambulatory artificial lungs. The company's devices help to improve the outcomes of those who suffer from acute and chronic lung problems, enabling physicians to treat end-stage lung failure that has limited treatments.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Acquirer
Corporate Office
  • 1500 Joh Avenue
  • Suite 190
  • Halethorpe, MD 21227
  • United States
+1 (410) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Breethe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 30-Apr-2020 $55M 000.00 0000 Completed Generating Revenue
7. Later Stage VC 09-Jul-2019 000 000.00 000.00 Completed Generating Revenue
6. Early Stage VC 26-Sep-2018 00.000 000.00 000.00 Completed Generating Revenue
5. Seed Round 19-Dec-2017 000 00.000 0000 Completed Generating Revenue
4. Seed Round 24-Aug-2017 00.000 00.000 000.00 Completed Generating Revenue
3. Seed Round 15-Aug-2016 00.000 00.000 000.00 Completed Generating Revenue
2. Seed Round 03-Sep-2015 $575K $1.39M 000.00 Completed Generating Revenue
1. Seed Round 23-Jan-2015 $810K $810K 000.00 Completed Generating Revenue
To view Breethe’s complete valuation and funding history, request access »

Breethe Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 6 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Series 5 0,000,000 00.000000 00.0 00.0 00 00.0 00.000
Seed-4 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Seed-3 000,000 00.000000 00.0 00.0 00 00.0 0.00
Seed-2 1,510,697 $0.000001 $1.87 $1.87 1x $1.87 6.51%
Seed 1,546,216 $0.000001 $1.48 $1.48 1x $1.48 6.66%
To view Breethe’s complete cap table history, request access »

Breethe Patents

Breethe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3209166-A1 Improved centrifugal blood pump Pending 09-Apr-2021 0000000000
AU-2022253277-A1 Improved centrifugal blood pump Pending 09-Apr-2021 0000000000
EP-4277691-A1 Improved centrifugal blood pump Pending 09-Apr-2021 0000000000
JP-2020531091-A Dual chamber gas exchanger for respiratory assistance and how to use it Active 15-Aug-2017 0000000000 0
EP-3668556-A4 Dual chamber gas exchanger and method of use for respiratory support Pending 15-Aug-2017 A61M1/1698 0
To view Breethe’s complete patent history, request access »

Breethe Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Breethe Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
The Abell Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
UM Ventures Venture Capital Minority 000 0000 000000 0
To view Breethe’s complete investors history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »